Gainers

• Regentis Biomaterials (AMEX:RGNT) stock rose 370.7% to $7.06 during Monday's regular session. The market value of their outstanding shares is at $7.7 million.
• Cuprina Holdings (Cayman) (NASDAQ:CUPR) stock rose 133.12% to $9.26. The market value of their outstanding shares is at $10.6 million.
• QTREX Quantum (NASDAQ:QTEX) shares increased by 67.31% to $2.16. The market value of their outstanding shares is at $58.3 million.
• Gelteq (NASDAQ:GELS) shares rose 29.29% to $1.28. The company's market cap stands at $10.6 million.
• Cypherpunk Technologies (NASDAQ:CYPH) stock moved upwards by 25.66% to $0.82. The market value of their outstanding shares is at $69.2 million.
• SAB Biotherapeutics (NASDAQ:SABS) shares rose 22.82% to $4.09. The company's market cap stands at $254.6 million.

Losers

• Elicio Therapeutics (NASDAQ:ELTX) stock fell 72.1% to $4.15 during Monday's regular session. The company's market cap stands at $283.4 million.
• Context Therapeutics (NASDAQ:CNTX) stock decreased by 49.93% to $0.7. The company's market cap stands at $127.7 million.
• Neumora Therapeutics (NASDAQ:NMRA) stock declined by 48.32% to $0.92. The market value of their outstanding shares is at $329.8 million.
• 20/20 Biolabs (NASDAQ:AIDX) stock fell 34.74% to $0.63. The market value of their outstanding shares is at $10.2 million.
• Traws Pharma (NASDAQ:TRAW) shares declined by 27.04% to $0.93. The company's market cap stands at $19.3 million.
• Genprex (NASDAQ:GNPX) stock fell 23.62% to $0.49. The company's market cap stands at $6.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.